Blue Moon Group Holdings Limited (6993.HK)
HKD 3.8
(0.0%)
HKD 3.8
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.61 Billion HKD | -2.36% |
| 2022 | 1.65 Billion HKD | -23.48% |
| 2021 | 2.16 Billion HKD | -47.49% |
| 2020 | 4.12 Billion HKD | 89.37% |
| 2019 | 2.17 Billion HKD | -10.4% |
| 2018 | 2.43 Billion HKD | -19.18% |
| 2017 | 3 Billion HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.37 Billion HKD | 0.0% |
| 2023 Q4 | 1.61 Billion HKD | -3.33% |
| 2023 Q2 | 1.94 Billion HKD | 0.0% |
| 2023 Q1 | 1.94 Billion HKD | 17.24% |
| 2023 FY | 1.61 Billion HKD | -2.36% |
| 2023 Q3 | 1.67 Billion HKD | -13.85% |
| 2022 Q2 | 2.04 Billion HKD | 0.0% |
| 2022 FY | 1.65 Billion HKD | -23.48% |
| 2022 Q4 | 1.65 Billion HKD | 0.0% |
| 2022 Q3 | 1.65 Billion HKD | -19.03% |
| 2022 Q1 | 2.04 Billion HKD | -5.49% |
| 2021 Q1 | 1.45 Billion HKD | -64.71% |
| 2021 FY | 2.16 Billion HKD | -47.49% |
| 2021 Q4 | 2.16 Billion HKD | 0.0% |
| 2021 Q3 | 2.16 Billion HKD | 48.78% |
| 2021 Q2 | 1.45 Billion HKD | 0.0% |
| 2020 Q4 | 4.12 Billion HKD | 0.0% |
| 2020 Q2 | 1.42 Billion HKD | 0.0% |
| 2020 Q1 | 1.42 Billion HKD | -34.36% |
| 2020 FY | 4.12 Billion HKD | 89.37% |
| 2020 Q3 | 4.12 Billion HKD | 188.51% |
| 2019 Q4 | 2.17 Billion HKD | 0.0% |
| 2019 Q1 | - HKD | 0.0% |
| 2019 FY | 2.17 Billion HKD | -10.4% |
| 2019 Q3 | 2.17 Billion HKD | 0.0% |
| 2018 FY | 2.43 Billion HKD | -19.18% |
| 2017 FY | 3 Billion HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -425.17% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | -52.11% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -1382.876% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -813.467% |
| Huasheng International Holding Limited | 675.58 Million HKD | -139.472% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -2517.641% |
| Evergreen Products Group Limited | 786.46 Million HKD | -105.709% |
| EC Healthcare | 2.97 Billion HKD | 45.533% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | -109.561% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -839.115% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -3675.661% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -792.115% |